To determine the potential involvement of HDAC expression patterns in multidrug resistance of AML, the expression of HDACs (HDAC1–11) in five cases of refractory AML was compared to that of five cases of remission AML. This evidence concerns the gene HDAC9 and acute myeloid leukemia.